From: Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
Sp6 MAb
MM1 MAb
Tertiles
CAIA
Human
I
≤ 19
≤ 30
≤ 12
≤ 20
II
20-37
31-42
13-24
21-40
III
≥ 38
≥ 43
≥ 25
≥ 41